Home
About
Publications Trends
Recent Publications
Expert Search
Archive
changes in bowel or bladder habits
What About Changes in Bladder Habits?
Changes in bladder habits, such as increased frequency of urination or blood in the urine, can be symptoms of
bladder cancer
or
prostate cancer
. These symptoms warrant a medical consultation to rule out cancer or other serious conditions.
Frequently asked queries:
What are Changes in Bowel or Bladder Habits?
How Do Changes in Bowel Habits Relate to Cancer?
What About Changes in Bladder Habits?
How Are These Symptoms Diagnosed?
How Can You Monitor These Symptoms?
What is Replication in Cancer?
What is Aspartate Aminotransferase (AST)?
What Causes a Cough in Cancer Patients?
How long does cancer treatment typically take?
How Does Socioeconomic Status Affect Cancer Risk?
What is the Impact of Hormonal Regulation?
How Can Cancer Patients Decrease Their Risk of Infection?
What are Some Notable Studies and Clinical Trials?
How do comorbid conditions affect cancer demographics?
How is a Needle Biopsy Performed?
How to Find a Holistic Cancer Care Provider?
How Can Healthcare Providers Facilitate Smooth Claim Submission?
What Should Patients Know Before Using Contrast Agents?
Which Cancers are Linked to HPV?
What Are the Risks of Using NSAIDs?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe